RENIBUS THERAPEUTICS INC has a total of 15 patent applications. Its first patent ever was published in 2019. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are HUMANWELL PURACAP PHARMACEUTICALS WUHAN CO LTD, LIU SHENGMEI and ZHEJIANG DKCOM ANIMAL HEALTH PRODUCTS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Guillem Alvaro F | 13 |
#2 | Keyser Donald Jeffrey | 13 |
#3 | Zager Richard A | 13 |
#4 | Donald Jeffrey Keyser | 2 |
#5 | Alvaro F Guillem | 2 |
#6 | Richard A Zager | 2 |
#7 | Singh Bhupinder | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020181256A1 | Novel tetrahydrocurcumin compositions, methods of making, and methods of using the same | |
WO2020176894A1 | Novel iron compositions and methods of making and using the same | |
US2020171051A1 | Methods for treating renal injury by therapeutically upregulating p21 | |
US2020057076A1 | Methods of treating patients at risk for renal injury and renal failure |